Clinical Trials

NHS‑Backed Trial of Galleri Blood Test Fails to Meet Main Goal

The three‑year study reported a drop in stage‑4 cancers accompanied by a rise in stage‑3 cases, prompting officials to withhold NHS approval pending further analysis.